Bharat Book Bureau

Choices in Cord Blood Banking Factors Influencing Parental Decision Making

Cord blood banking is increasingly being used to improve and save lives. Stem cells derived from umbilical blood have been used in more than 14,000 transplants worldwide to treat a wide range of blood diseases, genetic and metabolic disorders, immunodeficiencies and various forms of cancer. However, many expectant parents still do not fully understand the significance of cord blood storage. A study published in the Journal of Reproductive Medicine shows that a third of expectant parents are unaware of the option to preserve cord blood. Of the two-thirds who have some knowledge, 74% describe themselves as ¡§minimally informed.¨

Part 1 of this market report used proprietary data-derivation techniques to analyze conditions of the cord blood banking industry. Part 2 of this report used an end-user survey of expectant parents to identify and analyze the factors involved in the decision to privately store, publicly donate, or discard cord blood at birth. More than 1,200 expectation parents throughout the U.S., as well as Canada, Mexico, Europe, Asia, South/Central America, Australia and other regions answered the detailed survey between November 2008 and January 2009.
The report includes:

Sources through which expectant parents learn of cord blood banking
Rates of parental awareness of cord blood banking by gender, household income, geographic location, education, birth order, and other critical factors
Reasons parents cite as driving the decision to store cord blood
Factors influencing the decision for private vs. public storage of cord blood
Price sensitivity and quality expectations
Comparative analysis of quality variables among cord blood banks and parent perceptions of them
Parental responsiveness to health statistics
Differences in perspective based on global region, as well as differences due to location (city vs. suburban vs. rural)
Critical trends in cord blood banking and the factors influencing them
Competitive analysis of the Cord Blood Banking Industry, including:

U.S. Public Cord Blood Banks
U.S. Private Cord Blood Banks
International Public Cord Blood Banks
International Private Cord Blood Banks
Population Profiling: Characteristics of those highly/moderately/least likely to purchase cord blood banking services

Methods to effectively communicate with your target audience: Expectant Parents
And much more…

Table of Contents:

PART 1: CORD BLOOD BANKING, INDUSTRY OVERVIEW
I. Abstract
II. Cord Blood Stem Cells

A. Fetal Cord Blood Characteristics

B. Existing Treatments

C. Future Applications

III. Cord Blood Banking Industry

A. History

B. Private vs. Public Cord Blood Banks

1. U.S. Public Banks

a. Overview

b. Number of Public Banks

c. Geographic  Distribution

2. U.S. Private Banks

a. Overview

b. Number of U.S. Private Banks

c. Geographic  Distribution

3. Free Programs for U.S. Families with Medical Need

4. International Banks

a. Overview

b. Number Private Cord Blood Banks by International Region

IV. Market Characterization

A. List of U.S.  Private Cord Blood Banks

B. List of U.S. Public Cord Blood Banks

C. U.S. Mail-In Donation Cord Blood Banks

D. Breakdown of Canadian Cord Blood Banks – Public vs. Private / AABB Accredited vs. Non-Accredited

E. International Cord Blood Banks

1. Mexican Cord Blood Banks

a. Private Banks

b. Public Banking System

2. South/Central American Cord Blood Banks

a. Private Banks

b. Public Banking System

3. United Kingdom Cord Blood Banks

a. Private Banks

b. Public Banking System

4. European Cord Blood Banks

a. Private Banks

b. Public Banking System

5. Middle Eastern Cord Blood Banks

a. Private Banks

b. Public Banking System

6. Indian Cord Blood Banks

a. Private Banks

b. Public Banking System

7. Asian Cord Blood Banks

a. Private Banks

b. Public Banking System

8. Australian / New Zealand Cord Blood Banks

a. Private Australian and New Zealand Cord Blood Banks

b. Public Cord Blood Banks by Australian State

i. New South Wales

ii. Victoria

iii. Queensland

iv. Western Austalia, South Australia, & Tasmania

9. African Cord Blood Banks

a. Private Banks

b. Public Banking System

F. List of International Public Cord Blood Banks (Alphabetical by Country)

G. Worldwide List of AABB Accredited Cord Blood Facilities

V. United States Cord Blood Banking Legislation

A. U.S. State

B. U.S. Federal

1. Institute of Medicine Recommendations Study

a. Overview

b. Key Recommendations

c. IOM Study Shapes National Public Health Policy

2. Presidential Executive Order Expanding Approved Stem Cell Lines in Ethically Responsible Ways

a. Background

b. The Order

3. The Stem Cell Therapeutic and Research Act of 2005

a. Background

b. Current Status of the Act

VI. International Analysis – Trends, Policies and Industry Conditions (by Country)

A. NORTH & SOUTH  AMERICA

1. Canada

2. Mexico

3. United States

4. Brazil

5. Chile

6. Colombia

B. ASIA

1. China

2. Japan

3. Korea

4. Malaysia

5. Taiwan

6. Singapore

7. Thailand

C. INDIA

D. AUSTRALIA & NEW ZEALAND

E. EUROPE

1. European Union

a. Policy Overview

b. NETCORD Foundation

2. France

3. Germany & Austria

4. Italy

5. Netherlands

6. Spain

7. Poland

8. Russian Federation

9. United Kingdom

VII. Cost Analysis: Cord Blood Banking

A. Reasons for Variation in Cord Blood Pricing

1. Companies have Flexibility in the Pricing that they Set

2. Companies have Variables in the Services that they Offer

3. Variable Fee Breakdowns

B. Range of Pricing for U.S. Cord Blood Companies (1-100th percentiles)

1. U.S. Cord Blood Banking Price Range (1-100th%)

2. Lowest U.S. Pricing

3. Highest U.S. Pricing

4. Average U.S. Cord Blood Costs (25-75th percentiles)

5. Median Cost of U.S. Storage (50% percentile)

C. Range of Pricing for Canadian Cord Blood Companies (1-100th percentiles)

1. Canadian Cord Blood Banking Price Range (1-100th%)

2. Lowest Canadian Pricing

3. Highest Canadian. Pricing

4. Average Canadian. Cord Blood Costs (25-75th percentiles)

5. Median Cost of Canadian Storage (50% percentile)

VIII. Comparative Analysis of Quality Variables

A. Technical Variables

1. Vapor-Phase Storage vs. Liquid-Phase Storage

2. Cryo-bags vs. Cryo-vials

3. Pentastarch vs. Hetastarch

4. Computer Controlled vs. Manual Rate Freezing

5. Whole Sample vs. Volume Reduction

6. High-Control vs. Low-Control Aseptic Processing

B. Corporate Variables

1. Corporate Stability

2. Scientific Expertise

PART 2: EXPECTANT PARENTS, SURVEY RESULTS & FINDINGS

I. Survey Overview

A. Survey Population

B. Characterization of Market Survey Respondents

1. Geographic Distribution of Market Survey Respondents

2. Household Income Distribution of Survey Respondents

a. All Respondents

b. U.S. Respondents

3. Respondent Breakdown by Race

4. Respondent Breakdown by Gender

5. Respondent Breakdown by Level of Education

6. Respondent Breakdown by Location (City vs. Suburban vs. Rural)

7. Regional Breakdown of U.S. Respondents

8. Demographic Conclusions

II. Rates of Awareness: Unaware / Minimally Informed / Moderately Informed / Knowledgeable

A. Overall

B. By Gender

C. By Household Income

1. All Respondents

2. U.S. Respondents

D. By Education

E. By Race

F. By Geographic Location

1. Region within U.S.

2. Location (City vs. Suburban vs. Rural)

G. By Number of Existing Children within Family (e.g. Birth Order)

III. Factors Influencing Awareness

A. Personal Exposure: Relative Impact of Family, Co-Workers, Peers

B. Informational Sources: Information Sites, Books Medical Pamphlets, Government Sources

C. Medical Exposure: General Doctors, Ob / Gyn, Midwifes, Nurse, Other

D. Promotional Sources:  Internet Advertisements, Print Advertisements, Radio, TV, Other

IV. Factors Influencing Parental Decision-Making

A. Factors Influencing the Decision Not to Store Cord Blood

1.  Knowledge Level

2.  Price Sensitivity

3.  Safety Concerns

4.  Lack of Access

5.  Misconceptions

B. Factors Influencing the Decision for Private vs. Public Storage of Cord Blood

1. Ethical Beliefs

2. Gender

3. Total Household Income

4. Level of Education (Highest Level Achieved by at Least One Parent)

5. Race

6. Geographic Location

a. Region within U.S.

b. City vs. Suburban vs. Rural

7.  Access to Reliable Healthcare

8.  Number of Existing Children within Family (Birth Order)

9.  Source of Knowledge

10. Perceived Support of Medical Staff

11. Family Medical History

C. International Analysis of Cord Blood Banking Perceptions (Region-by-Region)

V. Parental Responsiveness to Health Statistics

A.  Overview

B.  Health Statistics

C.  Health Statistic Conclusions

VI. Parental Expectations

A. Quality of Services

B. Willingness to Educate/Inform

C. Reputability of Organization

VII. Trends

A. Rates of Cord Blood Storage (units per year)

B. Rates of Parental Awareness

C. Cord Blood Research Publication Rates

D. Cord Blood Research Funding Levels

E. Cord Blood Patent Breakdown

F.  Rates of Cord Blood Research Product Development

VIII. Informative Websites: Online Sources Utilized by Expectant Parents

A. Overview of Websites

1. Information Only

2. Commercial Affiliation

B. Dominant Regional Websites (International Analysis)

C. Most Important Criteria Used to Identify Sites to Inform Decision-Making

D. Underlying Reasons for Visiting Online Resources

IX. Conclusions

A. Traits of a “Model Customer”

1. “Model Customer” for a Private Cord Blood Bank

2. “Model Customer” for a Public Cord Blood Bank

B. Ideal Price Range

C. Approaches for Communicating with Expectant Parents

For more information kindly visit
http://www.bharatbook.com/Market-Research-Reports/Choices-in-Cord-Blood-Banking-Factors-Influencing-Parental-Decision-Making.html

Choices in Cord Blood Banking Factors Influencing Parental Decision Making

Cord blood banking is increasingly being used to improve and save lives. Stem cells derived from umbilical blood have been used in more than 14,000 transplants worldwide to treat a wide range of blood diseases, genetic and metabolic disorders, immunodeficiencies and various forms of cancer. However, many expectant parents still do not fully understand the significance of cord blood storage. A study published in the Journal of Reproductive Medicine shows that a third of expectant parents are unaware of the option to preserve cord blood. Of the two-thirds who have some knowledge, 74% describe themselves as ¡§minimally informed.¨

Part 1 of this market report used proprietary data-derivation techniques to analyze conditions of the cord blood banking industry. Part 2 of this report used an end-user survey of expectant parents to identify and analyze the factors involved in the decision to privately store, publicly donate, or discard cord blood at birth. More than 1,200 expectation parents throughout the U.S., as well as Canada, Mexico, Europe, Asia, South/Central America, Australia and other regions answered the detailed survey between November 2008 and January 2009.

The report includes:

Sources through which expectant parents learn of cord blood banking
Rates of parental awareness of cord blood banking by gender, household income, geographic location, education, birth order, and other critical factors
Reasons parents cite as driving the decision to store cord blood
Factors influencing the decision for private vs. public storage of cord blood
Price sensitivity and quality expectations
Comparative analysis of quality variables among cord blood banks and parent perceptions of them
Parental responsiveness to health statistics
Differences in perspective based on global region, as well as differences due to location (city vs. suburban vs. rural)
Critical trends in cord blood banking and the factors influencing them
Competitive analysis of the Cord Blood Banking Industry, including:

U.S. Public Cord Blood Banks
U.S. Private Cord Blood Banks
International Public Cord Blood Banks
International Private Cord Blood Banks

Population Profiling: Characteristics of those highly/moderately/least likely to purchase cord blood banking services
Methods to effectively communicate with your target audience: Expectant Parents
And much more…

Table of Contents:

PART 1: CORD BLOOD BANKING, INDUSTRY OVERVIEW

I. Abstract

II. Cord Blood Stem Cells

A. Fetal Cord Blood Characteristics

B. Existing Treatments

C. Future Applications

III. Cord Blood Banking Industry
A. History
B. Private vs. Public Cord Blood Banks
1. U.S. Public Banks

a. Overview

b. Number of Public Banks

c. Geographic  Distribution

2. U.S. Private Banks
a. Overview

b. Number of U.S. Private Banks

c. Geographic  Distribution

3. Free Programs for U.S. Families with Medical Need

4. International Banks

a. Overview

b. Number Private Cord Blood Banks by International Region

IV. Market Characterization

A. List of U.S.  Private Cord Blood Banks

B. List of U.S. Public Cord Blood Banks

C. U.S. Mail-In Donation Cord Blood Banks

D. Breakdown of Canadian Cord Blood Banks – Public vs. Private / AABB Accredited vs. Non-Accredited

E. International Cord Blood Banks

1. Mexican Cord Blood Banks

a. Private Banks

b. Public Banking System

2. South/Central American Cord Blood Banks

a. Private Banks

b. Public Banking System

3. United Kingdom Cord Blood Banks

a. Private Banks

b. Public Banking System

4. European Cord Blood Banks

a. Private Banks

b. Public Banking System

5. Middle Eastern Cord Blood Banks

a. Private Banks

b. Public Banking System

6. Indian Cord Blood Banks

a. Private Banks

b. Public Banking System

7. Asian Cord Blood Banks

a. Private Banks

b. Public Banking System

8. Australian / New Zealand Cord Blood Banks

a. Private Australian and New Zealand Cord Blood Banks

b. Public Cord Blood Banks by Australian State

i. New South Wales

ii. Victoria

iii. Queensland

iv. Western Austalia, South Australia, & Tasmania

9. African Cord Blood Banks

a. Private Banks

b. Public Banking System

F. List of International Public Cord Blood Banks (Alphabetical by Country)

G. Worldwide List of AABB Accredited Cord Blood Facilities

V. United States Cord Blood Banking Legislation

A. U.S. State

B. U.S. Federal

1. Institute of Medicine Recommendations Study

a. Overview

b. Key Recommendations

c. IOM Study Shapes National Public Health Policy

2. Presidential Executive Order Expanding Approved Stem Cell Lines in Ethically Responsible Ways

a. Background

b. The Order

3. The Stem Cell Therapeutic and Research Act of 2005

a. Background

b. Current Status of the Act

VI. International Analysis – Trends, Policies and Industry Conditions (by Country)

A. NORTH & SOUTH  AMERICA

1. Canada

2. Mexico

3. United States

4. Brazil

5. Chile

6. Colombia

B. ASIA

1. China

2. Japan

3. Korea

4. Malaysia

5. Taiwan

6. Singapore

7. Thailand

C. INDIA

D. AUSTRALIA & NEW ZEALAND

E. EUROPE

1. European Union

a. Policy Overview

b. NETCORD Foundation
2. France

3. Germany & Austria

4. Italy

5. Netherlands

6. Spain

7. Poland

8. Russian Federation

9. United Kingdom

VII. Cost Analysis: Cord Blood Banking

A. Reasons for Variation in Cord Blood Pricing

1. Companies have Flexibility in the Pricing that they Set

2. Companies have Variables in the Services that they Offer

3. Variable Fee Breakdowns

B. Range of Pricing for U.S. Cord Blood Companies (1-100th percentiles)

1. U.S. Cord Blood Banking Price Range (1-100th%)

2. Lowest U.S. Pricing

3. Highest U.S. Pricing

4. Average U.S. Cord Blood Costs (25-75th percentiles)

5. Median Cost of U.S. Storage (50% percentile)

C. Range of Pricing for Canadian Cord Blood Companies (1-100th percentiles)

1. Canadian Cord Blood Banking Price Range (1-100th%)

2. Lowest Canadian Pricing

3. Highest Canadian. Pricing

4. Average Canadian. Cord Blood Costs (25-75th percentiles)

5. Median Cost of Canadian Storage (50% percentile)

VIII. Comparative Analysis of Quality Variables

A. Technical Variables

1. Vapor-Phase Storage vs. Liquid-Phase Storage

2. Cryo-bags vs. Cryo-vials

3. Pentastarch vs. Hetastarch

4. Computer Controlled vs. Manual Rate Freezing

5. Whole Sample vs. Volume Reduction

6. High-Control vs. Low-Control Aseptic Processing

B. Corporate Variables

1. Corporate Stability

2. Scientific Expertise

PART 2: EXPECTANT PARENTS, SURVEY RESULTS & FINDINGS

I. Survey Overview
A. Survey Population

B. Characterization of Market Survey Respondents

1. Geographic Distribution of Market Survey Respondents

2. Household Income Distribution of Survey Respondents

a. All Respondents

b. U.S. Respondents

3. Respondent Breakdown by Race

4. Respondent Breakdown by Gender

5. Respondent Breakdown by Level of Education

6. Respondent Breakdown by Location (City vs. Suburban vs. Rural)

7. Regional Breakdown of U.S. Respondents

8. Demographic Conclusions

II. Rates of Awareness: Unaware / Minimally Informed / Moderately Informed / Knowledgeable

A. Overall

B. By Gender

C. By Household Income

1. All Respondents

2. U.S. Respondents

D. By Education

E. By Race

F. By Geographic Location

1. Region within U.S.

2. Location (City vs. Suburban vs. Rural)

G. By Number of Existing Children within Family (e.g. Birth Order)

III. Factors Influencing Awareness

A. Personal Exposure: Relative Impact of Family, Co-Workers, Peers

B. Informational Sources: Information Sites, Books Medical Pamphlets, Government Sources

C. Medical Exposure: General Doctors, Ob / Gyn, Midwifes, Nurse, Other
D. Promotional Sources:  Internet Advertisements, Print Advertisements, Radio, TV, Other

IV. Factors Influencing Parental Decision-Making

A. Factors Influencing the Decision Not to Store Cord Blood

1.  Knowledge Level

2.  Price Sensitivity

3.  Safety Concerns

4.  Lack of Access

5.  Misconceptions

B. Factors Influencing the Decision for Private vs. Public Storage of Cord Blood

1. Ethical Beliefs

2. Gender

3. Total Household Income

4. Level of Education (Highest Level Achieved by at Least One Parent)

5. Race

6. Geographic Location

a. Region within U.S.

b. City vs. Suburban vs. Rural

7.  Access to Reliable Healthcare

8.  Number of Existing Children within Family (Birth Order)

9.  Source of Knowledge

10. Perceived Support of Medical Staff

11. Family Medical History

C. International Analysis of Cord Blood Banking Perceptions (Region-by-Region)

V. Parental Responsiveness to Health Statistics

A.  Overview

B.  Health Statistics

C.  Health Statistic Conclusions

VI. Parental Expectations

A. Quality of Services

B. Willingness to Educate/Inform

C. Reputability of Organization

VII. Trends

A. Rates of Cord Blood Storage (units per year)

B. Rates of Parental Awareness

C. Cord Blood Research Publication Rates

D. Cord Blood Research Funding Levels

E. Cord Blood Patent Breakdown

F.  Rates of Cord Blood Research Product Development

VIII. Informative Websites: Online Sources Utilized by Expectant Parents

A. Overview of Websites

1. Information Only

2. Commercial Affiliation

B. Dominant Regional Websites (International Analysis)

C. Most Important Criteria Used to Identify Sites to Inform Decision-Making

D. Underlying Reasons for Visiting Online Resources

IX. Conclusions

A. Traits of a “Model Customer”

1. “Model Customer” for a Private Cord Blood Bank

2. “Model Customer” for a Public Cord Blood Bank

B. Ideal Price Range

C. Approaches for Communicating with Expectant Parents

For more please visit
http://www.bharatbook.com/Market-Research-Reports/Choices-in-Cord-Blood-Banking-Factors-Influencing-Parental-Decision-Making.html

Nanotechnology Market Forecast  

Nanotechnology is going to pave the way for a revolution in materials, information and communication technology, medicine, genetics and so on as it starts moving from the laboratories to new markets. It helps to improve products and production processes with better characteristics or new functionalities. In coming years, products based on nanotechnology are expected to impact nearly all-industrial sectors and will enter the consumer markets in large quantities. Considering the future prospects of nanotechnology, countries across the world are investing heavily in this sector.

The global market for nanotechnologies is projected to grow at a CAGR of around 20% till 2013, says “Nanotechnology Market Forecast to 2013” an analytical study by RNCOS. The report also projects that market for nanotechnology incorporated in manufactured goods will worth US$ 1.6 Trillion, representing a CAGR of more than 49% in the forecast period (2009-2013). This growth will largely be driven by massive investment in nanotechnology R&D by both governments and corporates across the world.

According to our report findings, at the regional level, the Asia-Pacific region will experience the fastest growth in market for nanotechnology enabled goods, with CAGR pegged at around 52% in the forecast period, followed by Europe. The recent moves by the emerging markets such as India, China and Russia in the field of nanotechnology research and development will continue to the most prominent factors behind the growth in these countries.

Our updated and detailed research report evaluates the past, current and future scenario of the global nanotechnology market coupled with an overview of emerging trends. The report has segmented the nanotechnology market by application and R&D investment. It discusses the nanotechnology market by key countries showing their prominence in the sector together with the emerging nations in the domain. Besides, the report covers various growth potential areas in the nanotechnology market at the global level.
Table of Contents:

1. Analyst View
2. Research Methodology
3. Nanotechnology - An Overview
4. Key Market Trends and Developments
4.1 Technology Innovation
4.2 R&D Funding Activities
4.3 Government Support
4.4 Convergence
4.5 Commercialization
5. Global Nanotechnology Industry Performance and Future Outlook
5.1 R&D Funding
5.1.1 Government
5.1.2 Corporate
5.1.3 Venture Capital
5.2 Major Applications
5.2.1 Electronics
5.2.2 Energy
5.2.3 Cosmetics
5.2.4 Biomedical
5.2.5 Defense
5.3 Regional Segmentation
5.3.1 Key Countries
5.3.1.1 US
5.3.1.2 Germany
5.3.1.3 Japan
5.3.1.4 Korea
5.3.1.5 Taiwan
5.3.1.6 France
5.3.1.7 UK
5.3.2 Emerging Countries
5.3.2.1 China
5.3.2.2 Canada
5.3.2.3 Brazil
5.3.2.4 Chile
5.3.2.5 Argentina
5.3.2.6 Russia
5.3.2.7 Australia
6. Potential Growth Areas
6.1 Nano-enabled Wireless Handsets
6.2 Nano-water
6.3 Quantum Dots
6.4 Thin Film Lithium-ion Battery
6.5 Nanofibers
6.6 Medical Applications
6.7 Nanocoating
6.8 Education Services
7. Growth Inhibitors
7.1 Huge Investment Requirements
7.2 Lack of Training and Development
7.3 Health and Environment Concerns
7.4 Code of Ethics

List of Tables

Table 5-1: US - Federal Funding in Nanotechnology by Agency (Million US$), 2007-2009
Table 5-2: US - Nanotechnology Funding by Program Component Area (Million US$), 2007-2009
Table 5-3: US - List of Agencies Participated in NNI (2008)
Table 5-4: Japan - Practical Use of Nanotechnology (2004 to 2007)
Table 5-5: Japan - Nanotechnology Market by Application (Billion JPY), 2005, 2010, 2020 & 2030
Table 5-6: South Korea - Nanotechnology Investment Plan (Million US$), 2001-2004, 2005-2007 & 2007-2010
Table 5-7: France - Nanotechnology Roadmap (1999 to 2007)
Table 5-8: France - Nanotechnology RTB Centers with Main Area of Activity
Table 5-9: France - Nanotechnology Proximity Centers with Main Areas of Activity
Table 5-10: UK - Key Nanotechnology Research Centers with Main Areas of Activity (2008)
Table 5-11: Chile - Millennium Science Initiative (1999 & 2001-2006)
Table 5-12: Chile - Approved Nanotechnology Research Projects (2006)
Table 5-13: Chile - Nanotechnology Research Groups with their Funding Source
Table 5-14: Australia - Nanotechnology Funding by Government Agency (Million A$), 2007-08
Table 5-15: Australia - Government Funding by Area of Activity (Million A$), 2007-08
Table 6-1: Global - Nanofibers Market by Segment (Million US$), 2006-2008 & 2013

List of Charts

Figure 5-1: Global - Nanotechnology Market (Billion US$), 2007 & 2008
Figure 5-2: Global - Nanotechnology Market by Component (%), 2008
Figure 5-3: Global - Forecast for Nanotechnology Market (Billion US$), 2009 & 2013
Figure 5-4: Global - Forecast for Nanotechnology Market by Component (%), 2013
Figure 5-5: Global - Nanotechnology Funding (Billion US$), 2007 & 2008
Figure 5-6: Global - Nanotechnology Funding by Segment (%), 2008
Figure 5-7: Global - Government Funding in Nanotechnology (Billion US$), 2007 & 2008
Figure 5-8: Global - Government Funding in Nanotechnology by Leading Countries (Billion US$), 2007 & 2008
Figure 5-9: Global - Corporate Funding in Nanotechnology (Billion US$), 2007 & 2008
Figure 5-10: Global - Corporate Funding in Nanotechnology by Leading Countries (Billion US$), 2008
Figure 5-11: Global - Venture Capital Funding in Nanotechnology (Billion US$), 2007 & 2008
Figure 5-12: Global - Use of Nanoparticles in Electronic Applications (Million US$), 2006-2008
Figure 5-13: Global - Forecast for Use of Nanoparticles in Electronic Applications (Million US$), 2009 & 2013
Figure 5-14: Global - Use of Nanoparticles in Energy Applications (Million US$), 2006-2008
Figure 5-15: Global - Forecast for Use of Nanoparticles in Energy Applications (Million US$), 2009 & 2013
Figure 5-16: Global - Energy-related Market for Nanotechnologies (Billion US$), 2006, 2007 & 2013
Figure 5-17: Global - Use of Nanoparticles in Cosmetic Applications (Million US$), 2007 & 2013
Figure 5-18: Global - Use of Nanoparticles in Biomedical Applications (Million US$), 2007 & 2013
Figure 5-19: Global - Share of Defense in Nanotechnology Market (%), 2007 & 2015
Figure 5-20: Global - Use of Nanotechnology in Manufactured Goods (Billion US$), 2007, 2009 & 2013
Figure 5-21: Global - Use of Nanotechnology in Manufactured Goods by Region (%), 2007
Figure 5-22: Global - Forecast for Use of Nanotechnology in Manufactured Goods by Region (%), 2013
Figure 5-23: Global - Use of Nanotechnology in Manufactured Goods by Application (%), 2007
Figure 5-24: Europe - Focus of Nanotechnology Companies* by Application (%), 2007
Figure 5-25: Asia-Pacific - Focus of Nanotechnology Companies* by Application (%), 2007
Figure 5-26: US - Federal Funding in Nanotechnology (Million US$), 2007-2009
Figure 5-27: US - Nanotechnology-enabled Products Market (Billion US$), 2007 & 2013
Figure 5-28: Germany - Public Funding in Nanotechnology (Million Euro), 2006 & 2008
Figure 5-29: Germany - Distribution of Active Participants in Nanotechnology (%)
Figure 5-30: Japan - Public Funding for Nanotechnology/Materials (Billion JPY), FY 2006 to FY 2008
Figure 5-31: Japan - Government Funded Projects (2001 to 2014)
Figure 5-32: South Korea - Nanotechnology Investment (Billion KRW), 2005 & 2006
Figure 5-33: South Korea - Nanotechnology Investment by Area (Billion KRW), 2005 & 2006
Figure 5-34: South Korea - Nanotechnology Investment by Ministry (Billion KRW), 2005 & 2006
Figure 5-35: South Korea - Number of Patent Applications (2000-2006)
Figure 5-36: Taiwan - Nanotechnology Industry Output (Billion US$), 2008 & 2010
Figure 5-37: Taiwan - Nanotechnology Industry Output by Application (%), 2008
Figure 5-38: China - Nanotechnology Market (Billion US$), 2005, 2010 & 2015
Figure 5-39: China - Forecast for Share in Global Nanotechnology Market (%), 2010 & 2015
Figure 5-40: Canada - Nanotechnology Funding (Million C$), 2002-2006
Figure 5-41: British Columbia - Nanotechnology Research by Area (%)
Figure 5-42: British Columbia - Nanotechnology Funding (Million C$), 2002-2006
Figure 5-43: British Columbia - Nanotechnology Funding by Institute (in Million C$), 2002-2006
Figure 5-44: Brazil - PPA/FS Nanotechnology Funding (Million R$), 2004-2008
Figure 5-45: Brazil - Nanotechnology Projects in Progress by Type (Numbers), 2006
Figure 5-46: Argentina - Estimated Nanotechnology Funding (Million US$), 2005-2007
Figure 5-47: Russia - Nanotech Investment (Billion US$), 2008-2015
Figure 5-48: Russia - Nano-enabled Product Market (Billion US$), 2008-2015
Figure 5-49: Russia - Nano-enabled Product Exports (Billion US$), 2008-2015
Figure 5-50: Russia - Forecast for Share in Global Nanoindustry Products Market (%), 2015
Figure 6-1: Global - Nano-enabled Components Market in Wireless Handsets (Billion US$), 2008 & 2013
Figure 6-2: Global - Nano-water Market (Billion US$), 2007 & 2013
Figure 6-3: Global - Quantum Dots Market (Million US$), 2008 & 2013
Figure 6-4: Global - Forecast for Quantum Dots Market by Segment (%), 2013
Figure 6-5: Global - Lithium-ion Battery Market (Billion US$), 2008 & 2013
Figure 6-6: Global - Nanofibers Market (Million US$), 2006-2008
Figure 6-7: Global - Forecast for Nanofibers Market (Million US$), 2009 & 2013
Figure 6-8: Global - Medical Market for Nanotechnology Applications (Billion US$), 2007, 2008 & 2013
Figure 6-9: Global - Nanocoating Market (Billion US$), 2008 & 2013
 

For more information kindly visit
http://www.bharatbook.com/Market-Research-Reports/Nanotechnology-Market-Forecast.html